Next 10 |
2024-05-14 08:45:00 ET Summary Legend Biotech Corporation reported lower-than-expected Q1 earnings, reflecting struggles in Carvykti’s revenue generation despite strong market potential. Carvykti, despite superior indications compared to competitors, is hindered by high tox...
2024-05-08 15:15:51 ET 2seventy bio, Inc. (TSVT) Q1 2024 Earnings Conference Call May 8, 2024, 8:00 AM ET Company Participants Jenn Snyder - Senior Vice President, Corporate Affairs Chip Baird - Chief Executive Officer Vicki Eatwell - Chief Financial Officer ...
2024-05-08 07:08:38 ET More on 2seventy bio 2seventy Bio: Maximizing ABECMA's Potential To Fuel A Turnaround 2Seventy Bio, Inc. (TSVT) Q4 2023 Earnings Call Transcript Bristol-Myers posts Q1 beat despite growth headwinds Bristol Myers, 2seventy bio's Abecma a...
2024-05-07 13:19:48 ET More on 2seventy bio 2seventy Bio: Maximizing ABECMA's Potential To Fuel A Turnaround 2Seventy Bio, Inc. (TSVT) Q4 2023 Earnings Call Transcript Bristol-Myers posts Q1 beat despite growth headwinds Bristol Myers, 2seventy bio's Abecma a...
2seventy bio, Inc . (Nasdaq: TSVT) will announce its first quarter 2024 financial results on Wednesday, May 8, 2024. A conference call and webcast will be held at 8:00 a.m. ET. Participants can access the conference call live via webcast which will be available on the Investors and Media pa...
2024-04-25 10:00:28 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance BofA watched clients retract $2B last week as the S&P dropped ...
2024-04-25 07:56:55 ET More on Bristol-Myers Squibb Company Is Bristol Myers Squibb A Buy At These Bottom Levels? Bristol-Myers Squibb: Market Pessimism Won't Last Forever Bristol Myers Squibb: Seriously Undervalued At Peak Pessimism (Rating Upgrade) Bristol-...
2024-04-19 06:13:03 ET More on Bristol-Myers Squibb, Gilead, etc. Johnson & Johnson: Buy This Bargain Before It's Gone Bristol-Myers Squibb: Market Pessimism Won't Last Forever Johnson & Johnson (JNJ) Q1 2024 Earnings Call Transcript FDA approves Alvo...
2024-04-08 00:00:02 ET Citigroup analyst issues BUY recommendation for TSVT on April 7, 2024 04:22PM ET. The previous analyst recommendation was Buy. TSVT was trading at $4.92 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analys...
2024-04-06 08:38:09 ET More on Johnson & Johnson Johnson & Johnson: Self-Proclaimed 'Dividend King' Faces Tricky Outlook With Lawsuit And Medtech Tailwinds - Johnson & Johnson May Be Back Johnson & Johnson (JNJ) Barclays 26th Annual Global Healthcare ...
News, Short Squeeze, Breakout and More Instantly...
2seventy bio Inc. Company Name:
TSVT Stock Symbol:
NASDAQ Market:
2seventy bio, Inc . (Nasdaq: TSVT) will announce its first quarter 2024 financial results on Wednesday, May 8, 2024. A conference call and webcast will be held at 8:00 a.m. ET. Participants can access the conference call live via webcast which will be available on the Investors and Media pa...
Following an investigation announced in November last year, the FDA said on Thursday that it would now require boxed warnings??...
2024-04-08 00:00:02 ET Citigroup analyst issues BUY recommendation for TSVT on April 7, 2024 04:22PM ET. The previous analyst recommendation was Buy. TSVT was trading at $4.92 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analys...